The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPO.L Regulatory News (SPO)

  • There is currently no data for SPO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: 210819 Hardman - Sportech (SPO): Cash payout

19 Aug 2021 13:40

Hardman & Co Research Hardman & Co Research: 210819 Hardman - Sportech (SPO): Cash payout 19-Aug-2021 / 13:40 GMT/BST


Hardman & Co Research: Cash payout

Sportech (SPO) has announced plans to return £36m surplus cash to shareholders by way of a tender offer, at 40p for up to 47% of the issued share capital. Assuming the offer is all taken up, SPO will be left with 100m shares outstanding. The deal requires court approval to create the necessary distributable reserves. SPO also announced that it was in discussions to sell its terrestrial lottery business for ca.$14m. The potential upside from the newly agreed sports betting deal in Connecticut (CT) remains uncertain but could be significant. We see a range of values from 39p to 46p per share prior to the tender offer.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/cash-payout/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Jason Streets

+44(0)20 3693 7075

 

js@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1227734 19-Aug-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
17th Oct 20237:00 amRNSCancellation - Sportech PLC
16th Oct 20237:00 amRNSMatched Bargain Dealing Facility
13th Oct 20233:31 pmRNSHolding(s) in Company
12th Oct 20235:45 pmRNSSportech
9th Oct 20232:17 pmRNSHolding(s) in Company
5th Oct 202310:00 amRNSResult of General Meeting
28th Sep 202311:50 amRNSDirector/PDMR Shareholding
28th Sep 202310:03 amRNSHolding(s) in Company
28th Sep 20239:55 amRNSHolding(s) in Company
27th Sep 20234:00 pmRNSDirector/PDMR Shareholding
25th Sep 202312:21 pmRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSHolding(s) in Company
19th Sep 20237:00 amRNSPublication of Circular and Notice of GM
14th Sep 20237:00 amRNSNotification of Major Holdings
11th Sep 20237:01 amRNSProposed De-lisiting
11th Sep 20237:00 amRNSHalf-year Report
30th Aug 20232:02 pmRNSNotification of Major Holdings
27th Jul 20231:35 pmRNSCapital distribution dates
24th Jul 20235:25 pmRNSTotal Voting Rights and Distribution
19th Jul 202312:00 pmRNSResult of Meeting
28th Jun 20237:00 amRNSPosting of Circular, Notice of GM and Distribution
26th Jun 20237:00 amRNSShare Restructure, Distribution and GM
30th May 20235:48 pmRNSResult of AGM
30th May 20237:00 amRNSAGM Trading Update
5th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSFinal Results
28th Feb 20233:34 pmRNSNotification of Major Holdings
24th Jan 20237:35 amRNSFY 2022 pre-close update
4th Jan 20234:13 pmRNSNotification of Major Holdings
24th Oct 20228:30 amRNSDirector/PDMR Shareholding
17th Oct 20227:00 amRNSNotification of Major Holings
17th Oct 20227:00 amRNSNotification of Major Holdings
14th Oct 20229:44 amRNSNotification of Major Holdings
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
11th Oct 20224:41 pmRNSSecond Price Monitoring Extn
11th Oct 20224:35 pmRNSPrice Monitoring Extension
1st Sep 20227:00 amRNSInterim Results
24th Aug 20227:00 amRNSDirectorate Change
28th Jul 20227:00 amRNSDirectorate Change
31st May 20222:00 pmRNSResult of Annual General Meeting
31st May 20227:00 amRNSAGM Trading Update and Board Changes
25th May 20227:00 amRNSDirectorate Change
6th May 20227:00 amRNSNotice of Annual General Meeting
27th Apr 20227:00 amRNSStatement re Capital Distribution to Shareholders
14th Apr 20227:00 amRNSDirectorate Change
1st Apr 20227:00 amRNSDirectorate Changes
31st Mar 20227:00 amRNSFinal Results
22nd Mar 20221:42 pmRNSNotification of Major Holdings
22nd Mar 202211:09 amRNSNotification of Major Holdings
15th Mar 20224:46 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.